Your browser doesn't support javascript.
loading
Pyoderma Gangrenosum in a Patient with X-Linked Agammaglobulinemia
Annals of Dermatology ; : 476-478, 2017.
Article in English | WPRIM | ID: wpr-86511
ABSTRACT
X-linked agammaglobulinemia (XLA) is a primary immunodeficiency disorder caused by germline mutations of B-cell tyrosine kinase (BTK) gene. It is characterized by decreased serum immunoglobulins levels and circulating mature B cells. This defect in humoral immunity leads to increased susceptibility to infection. Pyoderma gangrenosum (PG) is an uncommon, ulcerating, neutrophilic dermatosis. Here we report PG in an 8-year-old patient with XLA. The patient received intravenous immunoglobulin treatment in conjunction with prednisone and topical application of 0.03% tacrolimus ointment and the ulcer was almost completely healed in the 2 weeks of follow-up. The coexistence has been rarely reported. XLA may be a possible cofactor in the pathogenesis of PG.
Subject(s)

Full text: Available Index: WPRIM (Western Pacific) Main subject: Pyoderma / Skin Diseases / Ulcer / X Chromosome / Protein-Tyrosine Kinases / Immunoglobulins / Prednisone / B-Lymphocytes / Follow-Up Studies / Tacrolimus Type of study: Observational study / Prognostic study Limits: Child / Humans Language: English Journal: Annals of Dermatology Year: 2017 Type: Article

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: WPRIM (Western Pacific) Main subject: Pyoderma / Skin Diseases / Ulcer / X Chromosome / Protein-Tyrosine Kinases / Immunoglobulins / Prednisone / B-Lymphocytes / Follow-Up Studies / Tacrolimus Type of study: Observational study / Prognostic study Limits: Child / Humans Language: English Journal: Annals of Dermatology Year: 2017 Type: Article